We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Volex Plc | LSE:VLX | London | Ordinary Share | GB0009390070 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.00 | 0.58% | 349.50 | 348.50 | 350.00 | 350.00 | 340.00 | 340.00 | 216,361 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 722.8M | 36.8M | 0.2031 | 17.23 | 634.05M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/10/2019 16:00 | Management expects to announce the reinstatement of a dividend at the time of the interim results in November 2019. | cboney | |
25/10/2019 15:50 | Anyone still awaiting the Divi like me? Pay day was Thursday 17th, so even coming from the US this is taking its time? | martinthebrave | |
21/10/2019 10:39 | Flurry of small buys.....quiet of late.....liquidity here can surprise...(both ways!) | soundbuy | |
21/10/2019 10:17 | Looks as though they are on the move, look far too cheap IMO. | spooky | |
10/10/2019 14:26 | A nice buy from our Exec. Chairman. Clearly in his opinion a disparity exists between the performance of the business and the price of its stock. | f15jcm | |
02/10/2019 08:24 | Private Investor Evening, 4th Nov, London (Yellowstone Advisory) 51 views Robert Mundy CEO and co-Founder of Research Tree. Ex Oil & Gas Analyst at Credit Suisse and Liberum. Elektron Technology (soon to be renamed Checkit), Mirriad, Volex and Allergy Therapeutics management are all presenting Companies: AGY, EKT, MIRI, VLX PRIVATE INVESTOR EVENING Monday 4th November Arrive at 5.15pm for registration Starts 5.30pm Ends approx. 8.00pm Location: Davy’s Wine Bar, Woolgate Exchange, 25 Basinghall Street, London, EC2V 5HA Yellowstone Advisory are hosting a Private Investor event on Monday 4th November. This is an opportunity for you to hear first-hand from company management followed by a Q&A session and refreshments. Elektron Technology (soon to be renamed Checkit), Mirriad, Volex and Allergy Therapeutics management are all presenting. If you would like to attend please email kate@yellowstoneadvi Note: Places are limited and allocated on a first come first served basis. Elektron Technology (Checkit plc): [EKT LN (CKT LN)] Elektron Technology creates and develops products and services that Connect, Monitor and Control. Checkit is an early stage high growth business that provides a real-time operations management system. MIRRIAD plc: [MIRI LN] Mirriad analyses and identifies brand insertion opportunities in entertainment content and partners with broadcasters and digital publishers to deliver in-video advertising. Volex plc: A leading global supplier of cable assembly solution servicing a diverse range of markets including consumer electronics, telecoms, data centres, medical equipment and the automotive industry. Allergy Therapeutics plc (AGY LN): A pioneering market leader in immunology with specialist experience in the research and development of allergy treatments. Focus on the direct treatment of the cause rather than just managing symptoms. Aluminium free vaccines with ultra-short course treatments to increase adherence. | igoe104 | |
26/9/2019 14:58 | Volex PLC 'a resilient, diversified business' delivering strong cashflow Volex PLC's (LON:VLX) Daren Morris tells Proactive London's Andrew Scott the business today is very different from the Volex people in the UK know. ''Today we have a business which is active in electronic manufacturing services - What we do is make cables, electronic components, printed circuit boards ... '' ''We have 13 factories around the world, 6000 employees and we supply lots and lots of products to household names''. ''We're running a business now that is delivering cashflow, we're in two segments which are growing pretty strongly and showing our return to health by paying a dividend''. | igoe104 | |
24/9/2019 20:37 | Does buywell know why buywell doesn't like it? Does buywell have a split personality? | maddox | |
23/9/2019 12:16 | Ruffer are keen - up to 19% from 18% | bbluesky | |
17/9/2019 22:05 | Mmm just ignore him, he knows nothing. | red ninja | |
17/9/2019 19:40 | I think buywell needs to do some more research. This company has been transformed over the past 4 years. It has a diversified customer base and a great position to capitalise on growth in data centres, medical treatment and electric vehicles. I’m looking forward to a great set of results this year and more to come. Massively under valued and under appreciated | reddevils1 | |
08/8/2019 15:06 | This is why | buywell3 | |
08/8/2019 15:05 | buywell doesn't like it | buywell3 | |
08/8/2019 14:44 | NR should take this private....... | soundbuy | |
02/8/2019 20:32 | Yes, lower copper helps. As by now the customer pricing for 2019 is predominantly fixed and the wire purchase cost will fall (if Cu stays low)..... The other interesting thing is the USD:RMB - that dollar strength is good for Volex - as is a weak pound as it makes the salaries of the senior guys cheaper - which can't be bad! | reddevils1 | |
02/8/2019 20:12 | About 50% of purchases are for wire. Most of that is copper. However VLX maintains futures purchase agreements with a rolling 12 month period to ensure they are hedged against excessive movemnets. | thorpematt | |
02/8/2019 16:46 | Should falling copper prices help here? | f15jcm | |
01/8/2019 23:00 | When Volex bought GTK in Dec 18 they paid part of the consideration in shares to the private equity seller. This seller is likely to have been the overhang. | reddevils1 | |
01/8/2019 16:54 | What overhang? | davr0s | |
01/8/2019 14:24 | hopefully that's the overhang has cleared now. | igoe104 | |
01/8/2019 10:41 | I've added. My largest holding. | f15jcm | |
31/7/2019 09:25 | Buying here. There is some nice buying coming in this morning. Have to take advantage of any fund mangler giving their stock away cheap, because it won't last long imo. Stock has retreated from the recent highs of around 100 with the market selling this off (almost 15%) expecting some form of very toned down/cautious update. That update was good and is setting up for consensus upgrades later this year imo. The acquisition appears to be growing like the clappers, and with the leveraged footprint provided by Volex, I suspect that could well surprise to the upside also. What we ultimately have now have is a significantly lower valuation with much more confidence in the earnings as well as the earnings enhancing acquisition. I'll be surprised if the market doesn't factor these in very soon and drive the stock to new highs above 100. Update 01/08/2019: Chairman (53,876)and CFO (20,000) both buying stock. | sphere25 | |
31/7/2019 08:52 | Who is the seller here? Its been going on for months and there hasn't been a holdings announcement for more than a year. | spooky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions